No results for ‘’
Mercury Laboratories Ltd
₹850.70
(12.11%)
Sun, 21 Jun 2026, 03:08 am
Health Technology
Pharmaceuticals: Major
24.5KMercury Laboratories Enterprise Value (EV)
| Particulars | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 1.43 | 13.28 | 17.75 | 23.24 | 14.34 | 10.45 | 14.45 | 16.34 | 12.59 | 17.66 | 31.25 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0.26 | 2.38 | 1.96 | 1.78 | 1.40 | 1.05 | 2.09 | 1.44 | 1.54 | 1.96 | 1.83 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0.11 | 1.10 | 1 | 0.90 | 0.73 | 0.59 | 1.12 | 1 | 0.93 | 1.32 | 1.31 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 1.36 | 0 | 46.59 | 11.53 | 9.84 | 7.21 | 10.18 | 12.27 | 32.85 | 12.69 | 27.14 |
| Enterprise value | 0 | 0 | 0 | 0 | 12.43Cr | 58.21Cr | 54Cr | 52.77Cr | 48.76Cr | 38.4Cr | 79.34Cr | 57.25Cr | 68.77Cr | 97.18Cr | 102Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 2.10 | 8.81 | 7.62 | 11.62 | 8.34 | 6.08 | 7.76 | 7.83 | 7.86 | 10.60 | 14.21 |
| Debt to equity ratio | 0.34 | 0.32 | 0.70 | 0.73 | 0.49 | 0.34 | 0.30 | 0.37 | 0.33 | 0.22 | 0.19 | 0.15 | 0.13 | 0.11 | 0.10 |
| Return on equity % | 0 | 25.59 | 22.62 | 23.18 | 19.75 | 19.62 | 11.67 | 7.91 | 10.26 | 10.59 | 15.50 | 9.23 | 12.98 | 11.72 | 6.02 |
Mercury Laboratories Ltd Enterprise Value
The Mercury Laboratories Ltd Enterprise Value is a key financial metric used by investors to evaluate Mercury Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Mercury Laboratories Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Mercury Laboratories Ltd (NSE: , BSE: 538964) is currently trading at ₹850.70, with a market capitalization of ₹91.06Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Mercury Laboratories Ltd Enterprise Value is essential for fundamental analysis.
Mercury Laboratories Ltd Enterprise Value Current Value
The current Mercury Laboratories Ltd Enterprise Value stands at 102Cr.
The latest Mercury Laboratories Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Mercury Laboratories Ltd Enterprise Value Historical Trend
The Mercury Laboratories Ltd Enterprise Value has shown the following historical trend:
- 2024: 102Cr
- 2023: 97.18Cr
- 2022: 68.77Cr
- 2021: 57.25Cr
- 2020: 79.34Cr
The recent rise in Mercury Laboratories Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Mercury Laboratories Ltd Enterprise Value Indicates for Investors
The Mercury Laboratories Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Mercury Laboratories Ltd.
Mercury Laboratories Ltd Enterprise Value Analysis Summary
The Mercury Laboratories Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Mercury Laboratories Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Mercury Laboratories Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.